These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 9716098)
21. Reprivatizing pharmaceutical supplies in Africa. Turshen M J Public Health Policy; 2001; 22(2):198-225. PubMed ID: 11469153 [TBL] [Abstract][Full Text] [Related]
22. When is a market not a market? MacLeod SM CMAJ; 1993 Jan; 148(1):23-5. PubMed ID: 8439886 [No Abstract] [Full Text] [Related]
23. The pharmaceutical industry as a medicines provider. Henry D; Lexchin J Lancet; 2002 Nov; 360(9345):1590-5. PubMed ID: 12443614 [TBL] [Abstract][Full Text] [Related]
24. Lowering the cost of prescription drugs. Jindal B J La State Med Soc; 2003; 155(1):51. PubMed ID: 12656276 [No Abstract] [Full Text] [Related]
25. Pharma Dynamics: targeting safe, effective and affordable medication for South Africa and neighbouring countries. Cardiovasc J Afr; 2009; 20(1):85. PubMed ID: 19287824 [No Abstract] [Full Text] [Related]
27. The GO License: only part of the solution. Batson A; Milstien JB Health Aff (Millwood); 2008; 27(1):140-2. PubMed ID: 18180489 [TBL] [Abstract][Full Text] [Related]
28. International prices and availability of pharmaceuticals in 2005. Danzon PM; Furukawa MF Health Aff (Millwood); 2008; 27(1):221-33. PubMed ID: 18180499 [TBL] [Abstract][Full Text] [Related]
29. The interaction between intellectual property and drug regulatory systems: global perspectives. Madden EA IDrugs; 2007 Feb; 10(2):116-20. PubMed ID: 17285464 [TBL] [Abstract][Full Text] [Related]
30. After years of steady growth, winds of restraint blowing on prescription-drug industry. Robinson A CMAJ; 1995 Jul; 153(1):85-8. PubMed ID: 7796380 [TBL] [Abstract][Full Text] [Related]
31. Sparks fly over patents and vital drugs at world health assembly. Kapp C Lancet; 2003 May; 361(9372):1873. PubMed ID: 12788578 [No Abstract] [Full Text] [Related]
32. The Health Impact Fund. Light DW Lancet; 2010 Mar; 375(9718):893. PubMed ID: 20226984 [No Abstract] [Full Text] [Related]
33. It's time to look at Rx pricing. Why study reimporting Canadian drugs when the real issue is U.S. prices? Sloane T Mod Healthc; 2004 Mar; 34(11):18. PubMed ID: 15069795 [No Abstract] [Full Text] [Related]
34. Academics should use their intellectual property to produce cheap drugs for poor countries. Watts G BMJ; 2007 May; 334(7603):1079. PubMed ID: 17525425 [No Abstract] [Full Text] [Related]
35. Canada's plan to sell generic drugs to developing countries is threatened. Spurgeon D BMJ; 2004 Mar; 328(7442):728. PubMed ID: 15044278 [No Abstract] [Full Text] [Related]
38. TRIPS: whose interests are being served? Kamal M; Bailey M Lancet; 2003 Jul; 362(9380):260. PubMed ID: 12892952 [No Abstract] [Full Text] [Related]
39. International Generic Pharmaceutical Alliance - 12th Annual Conference. Part 2. Kuhrt K IDrugs; 2009 Dec; 12(12):765-9. PubMed ID: 19943218 [TBL] [Abstract][Full Text] [Related]
40. A few specialty drug prices fall--all generics. Manag Care; 2008 Dec; 17(12):46. PubMed ID: 19127766 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]